H.C. Wainwright has revised its price target for Quantum-Si (QSI, Financial), reducing it from $5.50 to $4 following the company's first-quarter financial results. Despite the lowered revenue figures compared to initial predictions, the firm continues to endorse a Buy rating on the stock. Analysts highlight that specific segments within Quantum-Si's operations show promising potential to drive growth in the short term. The firm remains optimistic about the company's ability to achieve "sustainable growth" moving forward.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for Quantum-Si Inc (QSI, Financial) is $3.33 with a high estimate of $5.50 and a low estimate of $1.00. The average target implies an upside of 125.23% from the current price of $1.48. More detailed estimate data can be found on the Quantum-Si Inc (QSI) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, Quantum-Si Inc's (QSI, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
QSI Key Business Developments
Release Date: May 15, 2025
- Revenue: $842,000 in Q1 2025, an 84% increase over Q1 2024.
- Gross Profit: $486,000 in Q1 2025.
- Gross Margin: 58% in Q1 2025.
- GAAP Operating Expenses: $25.6 million in Q1 2025, compared to $23.6 million in Q1 2024.
- Adjusted Operating Expenses: $22.9 million in Q1 2025, compared to $21.9 million in Q1 2024.
- Dividend and Interest Income: $2.5 million in Q1 2025, compared to $3.6 million in Q1 2024.
- Cash and Cash Equivalents: $232.6 million as of March 31, 2025.
- Projected Adjusted Operating Expenses for 2025: $103 million or less.
- Projected Total Cash Used for 2025: $95 million or less.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- Quantum-Si Inc (QSI, Financial) reported a significant 84% increase in first-quarter revenue compared to the same period in 2024, reaching $842,000.
- The company successfully launched the Platinum Pro system and completed its first customer sales, marking a key milestone in their commercial adoption strategy.
- Quantum-Si Inc (QSI) has expanded its international presence with 23 distribution partners, showing strong performance and interest in international markets.
- The company remains on track to launch its version 4 Sequencing Kit in the third quarter of 2025, which is expected to enhance proteome coverage and amino acid detection.
- Quantum-Si Inc (QSI) has a strong balance sheet with $232.6 million in cash and cash equivalents, providing financial runway into the second half of 2027.
Negative Points
- The company experienced a slowdown in new instrument purchases in the US academic market due to uncertainties related to NIH funding and indirect cost caps.
- First-quarter revenue, although increased, was slightly below the company's expectations.
- Operating expenses increased to $25.6 million in Q1 2025 from $23.6 million in Q1 2024, indicating rising costs.
- The company faces potential impacts from evolving tariffs, which could affect inventory acquisition costs and sales channels outside the United States.
- Quantum-Si Inc (QSI) is unable to provide clear top-line financial guidance due to ongoing uncertainties in the NIH funding environment.
